|
|
Tuesday, April 15, 2008
Anaphore Raises $8M, Launches Firm
San Diego-based Anaphore announced Tuesday that the firm has created a new company focused on protein therapeutics, and raised $8M in funding. The funding came from 5AM Ventures and Versant Ventures. According to Anaphore, it was created through the acquisition of Borean Pharma ApS, a Danish biotechnology company. Richard Ulevitch of 5AM Ventures is co-founder of Anaphore, which has appointed Katherine Bowdish as CEO of the company. Bowdish was most recently President of Alexion Antibody Technologies. Anaphore is targeting treatments for immune-based diseases.
posted on Tuesday, April 15, 2008 (Link to more information)
|
 RSS Feed
 Newsletter
Previous news:
Monday, July 7, 2008
Thursday, July 3, 2008
Wednesday, July 2, 2008
Tuesday, July 1, 2008
Monday, June 30, 2008
|
